This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Randomized, Sham-Injection Controlled, Double-Ma...
Clinical trial

A Randomized, Sham-Injection Controlled, Double-Masked, Multicenter trial of Ocriplasmin Intravitreal Injection for Treatment of Focal Vitreomacular Adhesion in Subjects with Exudative Age-Related Macular Degeneration (AMD)

Read time: 1 mins
Last updated:22nd May 2009
To evaluate the safety and preliminary efficacy of intravitreal ocriplasmin in patients with exudative AMD with focal vitreomacular adhesion
Category Value
Study start date 2009-05-22

View full details